Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Heart failure with non-reduced ejection fraction: Epidemiology, pathophysiology, phenotypes, diagnosis and treatment approaches.

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir - 1 May 2022

Çavuşoğlu Yüksel, Çelik Ahmet, Altay Hakan, Nalbantgil Sanem, Özden Özge, Temizhan Ahmet, Ural Dilek, Ünlü Serkan, Yılmaz Mehmet Birhan, Zoghi Mehdi

Abstract excerpt

Heart failure (HF) has been classified as reduced ejection fraction (HFrEF), mildly reduced ejection fraction (HFmrEF) and preserved ejection fraction (HFpEF) by the recent HF guidelines. In addition, HF with improved ejection fraction has been defined as a subgroup of HFrEF. In HFrEF, diagnostic workup and evidence-based pharmacological and device-based therapies have been well established. However, HFpEF, which...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Heart Failure
Share to Phenotype

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Prognosis

Share to Stroke Volume

Share to Ventricular Dysfunction, Left

Share to Ventricular Function, Left

Source

Identifiers

PMID: 35969235
DOI: 10.5543/tkda.2022.S1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Heart failure with non-reduced ejection fraction: Epidemiology, pathophysiology, phenotypes, diagnosis and treatment approaches.PMID 35969235Read ↗

Heart Failure with Preserved Ejection Fraction: The Pathophysiological Mechanisms behind the Clinical Phenotypes and the Therapeutic Approach.Semantic proximity Read ↗

Heart failure with preserved ejection fraction: Classification based upon phenotype is essential for diagnosis and treatment.Semantic proximity Read ↗

Primary heart failure with preserved ejection fraction: The intertwined pathophysiology and treatment of some of the most relevant phenotypes.Semantic proximity Read ↗

Insight into different phenotypic presentations of heart failure with preserved ejection fraction.Semantic proximity Read ↗

Epidemiology of heart failure with preserved ejection fraction.Semantic proximity Read ↗

Heart Failure with Reduced and Mildly Reduced Ejection Fraction: A Network Interpretive Framework of Mechanisms, Phenotypes, and Therapeutic Response.Semantic proximity Read ↗

Towards a phenotype profiling of the patients with heart failure and preserved ejection fractionSemantic proximity Read ↗

Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.Semantic proximity Read ↗

The future of heart failure with preserved ejection fraction : Deep phenotyping for targeted therapeutics.Semantic proximity Read ↗

Clinical Phenogroups in Heart Failure with Preserved Ejection Fraction.Semantic proximity Read ↗

Defining the Phenotypes for Heart Failure With Preserved Ejection Fraction.Semantic proximity Read ↗

Key Phenotypes of Heart Failure with Preserved Ejection Fraction: Pathophysiologic Mechanisms and Potential Treatment Strategies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.